Five-year survival of metastatic pancreatic carcinoma: a study of courage and hope
- PMID: 20084164
- PMCID: PMC2806805
Five-year survival of metastatic pancreatic carcinoma: a study of courage and hope
Erratum in
-
Errata.Gastrointest Cancer Res. 2009 Nov;3(6):258. Gastrointest Cancer Res. 2009. PMID: 21151432 Free PMC article.
Figures





Similar articles
-
Sustaining hope and life courage in patients undergoing ovarian cancer surgery - the impact of care.Eur J Cancer Care (Engl). 2018 Jan;27(1). doi: 10.1111/ecc.12562. Epub 2016 Aug 23. Eur J Cancer Care (Engl). 2018. PMID: 27550528
-
Entrepreneurs' Courage, Psychological Capital, and Life Satisfaction.Front Psychol. 2019 Apr 5;10:789. doi: 10.3389/fpsyg.2019.00789. eCollection 2019. Front Psychol. 2019. PMID: 31024410 Free PMC article.
-
Long-term survival for pancreatic cancer: a matter of hope, courage, or genetics?Gastrointest Cancer Res. 2011 Mar;4(2):67. Gastrointest Cancer Res. 2011. PMID: 21673878 Free PMC article. No abstract available.
-
Challenges and Role Changes in Caring for Adult Children With Cancer.J Adv Pract Oncol. 2018 Sep-Oct;9(6):634-638. Epub 2018 Sep 1. J Adv Pract Oncol. 2018. PMID: 31186984 Free PMC article. Review.
-
Pancreatic metastasis from renal carcinoma managed by Whipple resection. A case report and literature review of metastatic pattern, surgical management and outcome.JOP. 2009 Jul 6;10(4):413-8. JOP. 2009. PMID: 19581746 Review.
Cited by
-
Case report of long-term survival with metastatic triple-negative breast carcinoma: Treatment possibilities for metastatic disease.Medicine (Baltimore). 2019 Apr;98(16):e15302. doi: 10.1097/MD.0000000000015302. Medicine (Baltimore). 2019. PMID: 31008982 Free PMC article.
-
Can we cure stage IV triple-negative breast carcinoma?: Another case report of long-term survival (7 years).Medicine (Baltimore). 2019 Sep;98(38):e17251. doi: 10.1097/MD.0000000000017251. Medicine (Baltimore). 2019. PMID: 31567994 Free PMC article.
-
Long-Term Survivors in Metastatic Pancreatic Ductal Adenocarcinoma: A Retrospective and Matched Pair Analysis.Oncologist. 2019 Dec;24(12):1543-1548. doi: 10.1634/theoncologist.2018-0786. Epub 2019 Jun 4. Oncologist. 2019. PMID: 31164454 Free PMC article.
-
Low-Dose Continuous 5-Fluorouracil Combined with Leucovorin, nab-Paclitaxel, Oxaliplatin, and Bevacizumab for Patients with Advanced Pancreatic Cancer: A Retrospective Analysis.Target Oncol. 2018 Aug;13(4):461-468. doi: 10.1007/s11523-018-0572-3. Target Oncol. 2018. PMID: 29882102 Free PMC article.
-
Hepatic arterial therapy with drug-eluting beads in the management of metastatic pancreatic carcinoma to the liver: a multi-institutional registry.J Oncol. 2012;2012:168303. doi: 10.1155/2012/168303. Epub 2012 Feb 15. J Oncol. 2012. PMID: 22481917 Free PMC article.
References
-
- Gamelin L, Boisdron-Celle M, Delva R, et al. Prevention of oxaliplatin-related neurotoxicity by calcium and magnesium infusions: a retrospective study of 161 patients receiving oxaliplatin combined with 5-fluorouracil and leucovorin for advanced colorectal cancer. Clin Cancer Res. 2004;10:4055–4061. - PubMed
-
- Cascinu S, Catalano V, Cordella L, et al. Neuroprotective effect of reduced glutathione on oxaliplatin-based chemotherapy in advanced colorectal cancer: a randomized, double-blind, placebo-controlled trial. J Clin Oncol. 2002;20:3478–3483. - PubMed
-
- Boyle F, Monk R, Davey R, et al. Prevention of experimental paclitaxel neuropathy with glutamine. Proc Am Assoc Can Res. 1996;37:290. (abstr 1974)
-
- Savarese DMF, Savy G, Vahdat L, et al. Prevention of chemotherapy and radiation toxicity with glutamine. Cancer Treat Rev. 2003;29:501–513. - PubMed
-
- Wang W-S, Lin J-K, Lin T-C, et al. Oral glutamine is effective for preventing oxaliplatin-induced neuropathy in colorectal cancer patients. The Oncologist. 2007;12:312–331. - PubMed
Publication types
LinkOut - more resources
Full Text Sources